Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How do we mention S&L Warrant conversion issue in the letter?

How do we mention S&L Warrant conversion issue in the letter?

posted on Apr 19, 2007 09:28AM

Does anyone know exactly how many warrants have actually been converted and how many shares have been sold as a result? 

I don't think we can mention this issue until we have all of the facts - hopefully after Monday (4/23).

The S&L sell-off of shares due to converting warrant is currently only our "best guess" as to what's going on with the SP. 

 

Share
New Message
Please login to post a reply